State approaches to therapeutic interchange in community pharmacy settings: Legislative and regulatory authority

Thomas Vanderholm, Donald Klepser, Alex J. Adams

Research output: Contribution to journalReview article

Abstract

Therapeutic interchange is the act of switching a prescribed drug for another drug in the same therapeutic class that is believed to be therapeutically similar but may be chemically different. Therapeutic interchange is different from generic substitution in that it does not occur between therapeutically equivalent products; instead, products are substituted for those that are likely to have a substantially equivalent therapeutic effect generally at a lower cost. Therapeutic interchange is common in institutional settings across the United States but rarely occurs in community pharmacy settings without a pharmacist first contacting the original prescriber and requesting a new prescription in order to facilitate a change. As of 2018, Arkansas, Idaho, and Kentucky have passed laws to enable therapeutic interchange in community pharmacy settings. In general, these laws require the original prescriber to opt-in to allow therapeutic interchange, and the pharmacist generally must leverage the formulary of the patient’s health plan to guide decision making within the same therapeutic class. These 3 states require that the pharmacist notify the original prescriber of any interchange in order to ensure a complete and accurate medication record. When appropriately structured, state laws enabling therapeutic interchange in community pharmacy settings allow pharmacists to use their medication expertise to save valuable time and enhance patient care while reducing health care costs.

Original languageEnglish (US)
Pages (from-to)1260-1263
Number of pages4
JournalJournal of Managed Care and Specialty Pharmacy
Volume24
Issue number12
DOIs
StatePublished - Dec 1 2018

Fingerprint

Pharmacies
Interchanges
Pharmacists
Therapeutics
Drug Substitution
Formularies
Health care
Pharmaceutical Preparations
Therapeutic Uses
Costs
Health Care Costs
Substitution reactions
Prescriptions
Decision making
Decision Making
Patient Care
Health
Costs and Cost Analysis

ASJC Scopus subject areas

  • Pharmacy
  • Pharmaceutical Science
  • Health Policy

Cite this

State approaches to therapeutic interchange in community pharmacy settings : Legislative and regulatory authority. / Vanderholm, Thomas; Klepser, Donald; Adams, Alex J.

In: Journal of Managed Care and Specialty Pharmacy, Vol. 24, No. 12, 01.12.2018, p. 1260-1263.

Research output: Contribution to journalReview article

@article{c4400e1224fe4aadbd0bf82c0066719c,
title = "State approaches to therapeutic interchange in community pharmacy settings: Legislative and regulatory authority",
abstract = "Therapeutic interchange is the act of switching a prescribed drug for another drug in the same therapeutic class that is believed to be therapeutically similar but may be chemically different. Therapeutic interchange is different from generic substitution in that it does not occur between therapeutically equivalent products; instead, products are substituted for those that are likely to have a substantially equivalent therapeutic effect generally at a lower cost. Therapeutic interchange is common in institutional settings across the United States but rarely occurs in community pharmacy settings without a pharmacist first contacting the original prescriber and requesting a new prescription in order to facilitate a change. As of 2018, Arkansas, Idaho, and Kentucky have passed laws to enable therapeutic interchange in community pharmacy settings. In general, these laws require the original prescriber to opt-in to allow therapeutic interchange, and the pharmacist generally must leverage the formulary of the patient’s health plan to guide decision making within the same therapeutic class. These 3 states require that the pharmacist notify the original prescriber of any interchange in order to ensure a complete and accurate medication record. When appropriately structured, state laws enabling therapeutic interchange in community pharmacy settings allow pharmacists to use their medication expertise to save valuable time and enhance patient care while reducing health care costs.",
author = "Thomas Vanderholm and Donald Klepser and Adams, {Alex J.}",
year = "2018",
month = "12",
day = "1",
doi = "10.18553/jmcp.2018.24.12.1260",
language = "English (US)",
volume = "24",
pages = "1260--1263",
journal = "Journal of managed care & specialty pharmacy",
issn = "2376-0540",
publisher = "Academy of Managed Care Pharmacy (AMCP)",
number = "12",

}

TY - JOUR

T1 - State approaches to therapeutic interchange in community pharmacy settings

T2 - Legislative and regulatory authority

AU - Vanderholm, Thomas

AU - Klepser, Donald

AU - Adams, Alex J.

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Therapeutic interchange is the act of switching a prescribed drug for another drug in the same therapeutic class that is believed to be therapeutically similar but may be chemically different. Therapeutic interchange is different from generic substitution in that it does not occur between therapeutically equivalent products; instead, products are substituted for those that are likely to have a substantially equivalent therapeutic effect generally at a lower cost. Therapeutic interchange is common in institutional settings across the United States but rarely occurs in community pharmacy settings without a pharmacist first contacting the original prescriber and requesting a new prescription in order to facilitate a change. As of 2018, Arkansas, Idaho, and Kentucky have passed laws to enable therapeutic interchange in community pharmacy settings. In general, these laws require the original prescriber to opt-in to allow therapeutic interchange, and the pharmacist generally must leverage the formulary of the patient’s health plan to guide decision making within the same therapeutic class. These 3 states require that the pharmacist notify the original prescriber of any interchange in order to ensure a complete and accurate medication record. When appropriately structured, state laws enabling therapeutic interchange in community pharmacy settings allow pharmacists to use their medication expertise to save valuable time and enhance patient care while reducing health care costs.

AB - Therapeutic interchange is the act of switching a prescribed drug for another drug in the same therapeutic class that is believed to be therapeutically similar but may be chemically different. Therapeutic interchange is different from generic substitution in that it does not occur between therapeutically equivalent products; instead, products are substituted for those that are likely to have a substantially equivalent therapeutic effect generally at a lower cost. Therapeutic interchange is common in institutional settings across the United States but rarely occurs in community pharmacy settings without a pharmacist first contacting the original prescriber and requesting a new prescription in order to facilitate a change. As of 2018, Arkansas, Idaho, and Kentucky have passed laws to enable therapeutic interchange in community pharmacy settings. In general, these laws require the original prescriber to opt-in to allow therapeutic interchange, and the pharmacist generally must leverage the formulary of the patient’s health plan to guide decision making within the same therapeutic class. These 3 states require that the pharmacist notify the original prescriber of any interchange in order to ensure a complete and accurate medication record. When appropriately structured, state laws enabling therapeutic interchange in community pharmacy settings allow pharmacists to use their medication expertise to save valuable time and enhance patient care while reducing health care costs.

UR - http://www.scopus.com/inward/record.url?scp=85057196808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057196808&partnerID=8YFLogxK

U2 - 10.18553/jmcp.2018.24.12.1260

DO - 10.18553/jmcp.2018.24.12.1260

M3 - Review article

C2 - 30479203

AN - SCOPUS:85057196808

VL - 24

SP - 1260

EP - 1263

JO - Journal of managed care & specialty pharmacy

JF - Journal of managed care & specialty pharmacy

SN - 2376-0540

IS - 12

ER -